Ligand validation:6XDM

V1D: N-[(1S)-1-[4-(2-fluorophenyl)-1H-imidazol-2-yl]-7,7-dihydroxy-7-(1,2-oxazol-3-yl)heptyl]-1-methylazetidine-3-carboxamide

V1D is a Ligand Of Interest in 6XDM designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6XDM_V1D_C_410	57%	29%	0.111	0.884	2.16	0.73	3	1	0	0	100%	1
6XDM_V1D_B_408	56%	35%	0.115	0.884	1.88	0.7	3	1	0	0	100%	1
6XDM_V1D_A_411	55%	29%	0.121	0.89	2.03	0.84	3	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.